GFAP degradation in TBI: linking novel modified products to astrocyte pathology and patient outcome

2026-04-23 | GFAP degradation in TBI: linking novel modified products to astrocyte pathology and patient outcome – Acta Neuropathol. Commun. Wanner, I.-B.; Halford, J.; Lopez, J.; Shen, S.; Chen, Y.; Zhao, H.; Salas, C.; Loo, R. O.; Robicsek, S.; Ellingson, B. M.; Gornbein, J.; Van Meter, T. E.; Shaw, G.; Loo,^* J. A.; Vespa, P. M.